Gilmore Neil O'Neill

EDIT

Gilmore Neil O'Neill serves as director, officer: CEO at Editas Medicine, Inc. (EDIT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

10 trades

$993.0K

Net Position

Net Seller

$993.0K

Companies Traded

EDIT

Active Period

Jun 2023 – Jun 2026

10 total trades

Most Recent

Sell EDIT

Jun 5, 2026 · $41.5K

Gilmore Neil O'Neill's Insider Trading at Editas Medicine, Inc. (EDIT)

Buys

0 · $0.00

Sells

10 · $993.0K

Total Shares Bought

Total Shares Sold

158,073

EDIT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 5, 2026	Sell	15,380	$2.70	$41.5K	248,313
Dec 3, 2025	Sell	5,603	$2.15	$12.1K	0
Sep 3, 2025	Sell	5,592	$2.60	$14.5K	0
Jun 3, 2025	Sell	15,192	$1.72	$26.2K	0
Mar 4, 2025	Sell	16,632	$1.71	$28.5K	0
Dec 3, 2024	Sell	1,618	$2.08	$3.4K	0
Sep 4, 2024	Sell	1,555	$3.42	$5.3K	0
Jun 4, 2024	Sell	12,191	$5.50	$67.0K	0
Mar 2, 2024	Sell	77,824	$9.42	$732.9K	0
Jun 5, 2023	Sell	6,486	$9.50	$61.6K	0

Related Insiders

Linda Burkly

officer: EVP, CHIEF SCIENTIFIC OFFICER

EDITSell · Jun 5, 2026

Amy Parison

SVP, Chief Financial Officer

EDITSell · Jun 5, 2026

Explore More Insider Trading Data

EDIT Insider Trading Activity

View all insider trades at Editas Medicine, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity